Volume 8 - Issue 2 - February 2011

Christopher J. Cooper, MD and William R. Colyer, Jr., MD

In this issue of Vascular Disease Management we have a unique opportunity to obtain a global perspective on the management of renal artery stenosis. Certainly in the United States and Europe, management of atherosclerotic renal artery stenosis is an… | Read More

James Ritchie, MRCP and Philip A. Kalra, MD, FRCP

ABSTRACT: ASTRAL and the four randomized, controlled trials preceding have shown that unselected revascularization in atherosclerotic renovascular disease (ARVD) is not an appropriate intervention. Despite this, there are clinical situations where… | Read More

Thomas Zeller, MD, Aljoscha Rastan, MD, Elias Noory, MD

Amit Prasad, MD and Christopher J. White, MD

Introduction Hemodynamically significant renal artery stenosis (RAS) induces hypoperfusion of the affected kidney leading to a constellation of physiologic responses.1 Upregulation of the renin-angiotensin-aldosterone system (RAAS) results in… | Read More

William R. Colyer, Jr., MD

One of the challenges facing medicine today is how to best allocate resources. As medical costs continue to rise, agencies such as the Centers for Medicare & Medicaid Services (CMS) must ensure that money is spent in a responsible manner. This… | Read More

Debbie Nel, MBChB and Brian Rayner, MBChB, FCP MMed

ABSTRACT: The burden of HIV infection, particularly in Sub-Saharan Africa, is well documented. The consequences are far-reaching and go beyond those of opportunistic infection and malignancy and into the realm of chronic diseases of lifestyle, with… | Read More

Marcelo A. Agüero, MD, Pablo D. Liva, MD, Jorge A. Baccaro, MD

ABSTRACT: Renal artery aneurysms (RAAs) are being diagnosed with increasing frequency. They can be incidental or symptomatic. Rupture is the most feared complication. RAAs can be managed conservatively or treated with either surgery or an… | Read More